Physiology and pharmacology of nausea and vomiting

References 

1. Pan PH, Lee SC, Harris LC. Antiemetic prophylaxis for postdischarge nausea and vomiting and impact on functional quality of living during recovery in patients with high emetic risks: A prospective, randomized, double-blind comparison of two prophylactic antiemetic regimens. Anesth Analg. 2008;107:429–438
   • CrossRef
2. White PF, Sacan O, Nuangchamnong N, Sun T, Eng MR. The relationship between risk factors and early versus late postoperative emetic symptoms. Anesth Anal. 2008;107:459–463
3. Kovac AL, Eberhart L, Kotarski J, Clerici G, Apfel C. A randomised, double-blind study to evaluate the efficacy and safety of three different doses of palonosetron versus placebo in preventing postoperative nausea and vomiting over a 72-hour period. Anesth Analg. 2008;107:439–444
   • CrossRef
4. Diemunsch P, Gan TJ, Philip BK, et al. Single-dose aprepitant vs ondansetron for the prevention of postoperative nausea and vomiting: a randomised, double-blind phase III trial in patients undergoing open abdominal surgery. Br J Anaesth. 2007;99:202–211
   • CrossRef
5. Navari RM. Pharmacological management of chemotherapy-induced nausea and vomiting. Focus on recent developments. Drugs. 2009;69:515–533
   • CrossRef